Dermata Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	7.44	6.24	10.8	0.53	1.99
Cash & Cash Equivalents	7.44	6.24	10.8	0.53	1.99
Cash Growth	19.18%	-42.20%	1935.97%	-73.37%	-
Other Current Assets	-	-	0.83	0.08	0.07
Total Current Assets	-	-	11.62	0.61	2.07
Property, Plant & Equipment	0	0	0	0	0
Total Long-Term Assets	-	-	0	0	0
Total Assets	7.98	6.94	11.62	0.61	2.07
Accounts Payable	0.87	0.5	0.52	0.1	0.34
Current Debt	-	-	0	3.55	0.73
Other Current Liabilities	-	-	1	0.13	0.66
Total Current Liabilities	-	-	1.52	3.78	1.72
Long-Term Debt	-	-	0	0	0.55
Total Long-Term Liabilities	-	-	0	0	0.55
Total Liabilities	1.62	0.92	1.52	3.78	2.28
Total Debt	0	0	0	3.55	1.28
Debt Growth	-	-	-	176.20%	-
Retained Earnings	-53.39	-45.59	-35.98	-28.08	-24.84
Shareholders' Equity	6.36	6.02	10.11	-3.18	-0.21
Net Cash / Debt	7.44	6.24	10.8	-3.02	0.71
Net Cash / Debt Growth	19.18%	-42.20%	-	-	-
Net Cash Per Share	38.15	135.55	602.41	-378.66	88.92
Working Capital	-	-	10.11	-3.18	0.34
Book Value Per Share	32.60	130.78	563.83	-399.11	-26.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).